Search Results 7661-7670 of 33563 for oral
Oral Oncology Reports. 2025; 13:100695; Smith KER, Acosta-Medina AA, Dasari S, Ranatunga W, Rech KL, Ravindran A, Young JR, McGarrah PW, Ruan GJ, Zanwar SS ...
Research at Mayo Clinic in diabetic nephropathy includes developing new diagnostic and treatment tools, such as oral medicines that may help stop or delay ...
Criterion not applicable for participants on therapy with direct-acting oral anticoagulants (DOACs). Note: Other protocol defined Inclusion/Exclusion ...
Disease progression ≤ 1 year (365 days) from the last dose of an oral SERD including camizestrant. Note: Other protocol defined Inclusion/Exclusion ...
oral lobe seizure, Seizure , Absence seizure, Febrile seizure. Show more areas of focus for Anthony L. Fine, M.D.. Sanford M. Fineman ...
... Oral and throat cancer, Salivary gland cancer, Mouth cancer, Thyroid cancer, Head and neck cancer, Melanoma, Tonsil cancer, Skin cancer, Squamous cell ...
Current regular use of oral anti-hyperglycemia agents for the treatment of diabetes; Documented diabetes by American Diabetes Association and/or World Health ...
ructive surgery, Oral surgery, Skin cancer excision, Microvascular reconstruction, Transoral laser microsurgery, Facial reconstruction, Parotid gland ...
... Oral and throat cancer, Laryngeal cancer, Skin tumor. Show more areas of focus for Katie M. Van Abel, M.D.. Research. Mayo Clinic doctors and scientists are ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.